WARREN B. KANDERS - 18 Mar 2024 Form 4 Insider Report for Cadre Holdings, Inc. (CDRE)

Role
CEO AND CHAIRMAN, Director, 10%+ Owner
Signature
/s/ Warren B. Kanders
Issuer symbol
CDRE
Transactions as of
18 Mar 2024
Transactions value $
-$50,334,445
Form type
4
Filing time
20 Mar 2024, 16:17:52 UTC
Previous filing
15 Mar 2024
Next filing
10 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDRE Common Stock, par value $0.0001 per share ("Common Stock") Sale -$50.3M -1.44M -10.56% $35.00 12.2M 19 Mar 2024 By Kanders SAF, LLC F1, F5
holding CDRE Common Stock 24K 18 Mar 2024 Direct
holding CDRE Common Stock 1.31M 18 Mar 2024 By Warren B. Kanders Roth IRA
holding CDRE Common Stock 23.5K 18 Mar 2024 By Allison Kanders Roth IRA F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDRE Restricted Stock Units Award $0 +33.5K $0.00 33.5K 18 Mar 2024 Common Stock 33.5K Direct F3
transaction CDRE Stock Option (right to purchase) Award $0 +106K $0.00 106K 18 Mar 2024 Common Stock 106K $34.66 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the sole manager and member of Kanders SAF, LLC.
F2 Allison Kanders is the Reporting Person's spouse.
F3 Comprised of a restricted stock units award granted under the Cadre Holdings, Inc. (the "Issuer") 2021 Stock Incentive Plan (the "Plan") consisting of 33,540 shares of the Issuer's Common Stock. 11,180 shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 18, 2025, March 18, 2026 and March 13, 2027, respectively.
F4 The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 35,228 shares of the Issuer's Common Stock will vest and become exercisable on March 18, 2025 and options to purchase 35,227 shares of the Issuer's Common Stock will vest and become exercisable on each of March 18, 2026 and March 18, 2027, respectively.
F5 The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.